Dosiomics and Radiomics Guided Precision Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma Patients

被引:0
|
作者
Cui, Y. [1 ]
机构
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2250
引用
收藏
页码:E112 / E113
页数:2
相关论文
共 50 条
  • [1] Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma
    Nakashima, Yuichiro
    Saeki, Hiroshi
    Hu, Qingjiang
    Tsuda, Yasuo
    Hisamatsu, Yuichi
    Ando, Koji
    Oki, Eiji
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2018, 38 (12) : 6809 - 6814
  • [2] Radiomics and Dosiomics for Predicting Complete Response to Definitive Chemoradiotherapy Patients with Esophageal Squamous Cell Cancer with Hybrid Institution Model
    Kawahara, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E99 - E99
  • [3] Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
    Chen, Fei
    Qiu, Lingdong
    Mu, Yushu
    Sun, Shibin
    Yuan, Yulong
    Shang, Pan
    Ji, Bo
    Wang, Qifei
    FRONTIERS IN SURGERY, 2022, 9
  • [4] Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma
    Guo, Xufeng
    Chen, Chunji
    Zhao, Jinbo
    Wang, Changchun
    Mei, Xinyu
    Shen, Jianfei
    Lv, Huilai
    Han, Yongtao
    Wang, Qifeng
    Lv, Jiahua
    Chen, Hainan
    Yan, Xiaolong
    Liu, Zhichao
    Zhang, Zhengyang
    Zhong, Qihong
    Jiang, Youhua
    Xu, Liwei
    Li, Xiaoyang
    Qian, Dong
    Ma, Dehua
    Ye, Minhua
    Wang, Chunguo
    Wang, Zimin
    Lin, Jiangbo
    Tian, Ziqiang
    Leng, Xuefeng
    Li, Zhigang
    JAMA SURGERY, 2025,
  • [5] Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
    Liu, Yunsong
    Wang, Yi
    Hu, Xinyang
    Wang, Xin
    Xue, Liyan
    Pang, Qingsong
    Zhang, Huan
    Ma, Zeliang
    Deng, Heping
    Yang, Zhaoyang
    Sun, Xujie
    Men, Yu
    Ye, Feng
    Men, Kuo
    Qin, Jianjun
    Bi, Nan
    Zhang, Jing
    Wang, Qifeng
    Hui, Zhouguang
    INSIGHTS INTO IMAGING, 2024, 15 (01):
  • [6] Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma
    Kawai, Takaharu
    Kochi, Mitsugu
    Fujii, Masashi
    Song, Keio
    Hagiwara, Ken
    Watanabe, Megumu
    Matsuno, Yoritaka
    Suda, Hiroshi
    Yagi, Renpei
    Takayama, Tadatoshi
    ANTICANCER RESEARCH, 2017, 37 (06) : 3301 - 3306
  • [7] Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma
    Wen, Jing
    Fang, Shuogui
    Hu, Yi
    Xi, Mian
    Weng, Zelin
    Pan, Chuqing
    Luo, Kongjia
    Ling, Yihong
    Lai, Renchun
    Xie, Xiuying
    Lin, Xiaodan
    Lin, Ting
    Chen, Jiyang
    Liu, Qianwen
    Fu, Jianhua
    Yang, Hong
    EBIOMEDICINE, 2022, 86
  • [8] Neoadjuvant chemoradiotherapy for patients with squamous cell carcinoma of the oesophagus
    Pereira, AD
    Gloria, L
    Claro, I
    Chagas, C
    Oliveira, J
    Vaz, F
    Rodrigues, R
    Almeida, JC
    Leitao, CN
    Almeida, JM
    Fernandes, A
    Mira, FC
    GUT, 1997, 41 : A156 - A156
  • [9] Prediction of Neoadjuvant Chemoradiotherapy Sensitivity in Patients With Esophageal Squamous Cell Carcinoma Using CT-Based Radiomics Combined With Clinical Features
    Li, Xindi
    Dong, Jigang
    Li, Baosheng
    Aimei, Ouyang
    Sun, Yahong
    Wu, Xia
    Liu, Wenjuan
    Li, Ruobing
    Li, Zhongyuan
    Yang, Yu
    DOSE-RESPONSE, 2024, 22 (04):
  • [10] MR radiomics predicts pathological complete response of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a multicenter study
    Yunsong Liu
    Yi Wang
    Xin Wang
    Liyan Xue
    Huan Zhang
    Zeliang Ma
    Heping Deng
    Zhaoyang Yang
    Xujie Sun
    Yu Men
    Feng Ye
    Kuo Men
    Jianjun Qin
    Nan Bi
    Qifeng Wang
    Zhouguang Hui
    Cancer Imaging, 24